Showing results (221-230 of 1,521) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|April 8, 2026
Translational Modeling of Gut Microbiome-Mediated Drug Metabolism: A Case Example of SulfasalazineLisa Cheng, Jingwei Cai, Alexis Auster, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2026
Integration of Time-Varying Pharmacometric Modeling With Cox Regression for Time-to-Event Analysis in NONMEMChih-Wei Lin, Po-Wei Chen, Sameer Doshi, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 12, 2026
Adaptive Dosing Trial Simulation Framework to Inform Dose Optimization: Case Study Using Longitudinal PKPD Models With PF-06804103 Phase 1 Data in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive and Low Solid TumorsJerry Li, Li Zhou, Abraham C F Leung, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 27, 2026
Population PK-PD Modeling of Danicopan Add-On Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria Treated With Ravulizumab or EculizumabJun Chen, Feng Yang, Hanbin Li, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 24, 2026
Assessment and Benchmarking of Model Informed Approaches in Drug Development for Hemoglobinopathies: A Review of Scientific Advices From January 2000 to December 2024Grace Shalom Govere, Jean-Michel Dogné, Flora Musuamba
CPT: Pharmacometrics & Systems Pharmacology|February 19, 2026
Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung CancerRichard C Franzese, Li Qin, Shuai Fu, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 19, 2026
Retrieval Augmented Generation (RAG) for Evaluating Regulatory Compliance of Drug Information and Clinical Trial ProtocolsShreyas Waikar, Amruta Gajanan Bhat, Murali Ramanathan
CPT: Pharmacometrics & Systems Pharmacology|March 6, 2026
What Is a Digital Twin in QSP, and Are We Doing It Right?Justin Feigelman
CPT: Pharmacometrics & Systems Pharmacology|February 26, 2026
Population PK/PD Modeling for Evaluation of Intertwining Effects of Drug and Disease on Thrombocytopenia in Acute LeukemiasTomás Sou, Kamel Malek, Hans-Jochen Weber
CPT: Pharmacometrics & Systems Pharmacology|December 27, 2016
Quantitative Characterization of the Exposure-Response Relationship for Cancer Immunotherapy: A Case Study of Nivolumab in Patients With Advanced MelanomaX Wang, Y Feng, G Bajaj, et al.
Pageof 153